Interaction between intravenous thrombolysis and clinical outcome between slow and fast progressors undergoing mechanical thrombectomy: a post-hoc analysis of the SWIFT-DIRECT trial

医学 溶栓 事后 斯威夫特 析因分析 内科学 临床试验 急诊医学 麻醉 外科 心肌梗塞 计算机科学 程序设计语言
作者
Gaultier Marnat,Johannes Kaesmacher,Lukas Buetikofer,Igor Sibon,Suzana Saleme,Raoul Pop,Hilde Hénon,Patrik Michel,Mikaël Mazighi,Zsolt Kulcsár,Kévin Janot,Paolo Machi,Aleksandra Pikula,Jean‐Christophe Gentric,María Hernández‐Pérez,Lars Udo Krause,Guillaume Turc,David S. Liebeskind,Jan Gralla,Urs Fischer
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:16 (1): 45-52 被引量:10
标识
DOI:10.1136/jnis-2023-020113
摘要

Background In proximal occlusions, the effect of reperfusion therapies may differ between slow or fast progressors. We investigated the effect of intravenous thrombolysis (IVT) (with alteplase) plus mechanical thrombectomy (MT) versus thrombectomy alone among slow versus fast stroke progressors. Methods The SWIFT-DIRECT trial data were analyzed: 408 patients randomized to IVT+MT or MT alone. Infarct growth speed was defined by the number of points of decay in the initial Alberta Stroke Program Early CT Score (ASPECTS) divided by the onset-to-imaging time. The primary endpoint was 3-month functional independence (modified Rankin scale 0–2). In the primary analysis, the study population was dichotomized into slow and fast progressors using median infarct growth velocity. Secondary analysis was also conducted using quartiles of ASPECTS decay. Results We included 376 patients: 191 IVT+MT, 185 MT alone; median age 73 years (IQR 65–81); median initial National Institutes of Health Stroke Scale (NIHSS) 17 (IQR 13–20). The median infarct growth velocity was 1.2 points/hour. Overall, we did not observe a significant interaction between the infarct growth speed and the allocation to either randomization group on the odds of favourable outcome (P=0.68). In the IVT+MT group, odds of any intracranial hemorrhage (ICH) were significantly lower in slow progressors (22.8% vs 36.4%; OR 0.52, 95% CI 0.27 to 0.98) and higher among fast progressors (49.4% vs 26.8%; OR 2.62, 95% CI 1.42 to 4.82) (P value for interaction <0.001). Similar results were observed in secondary analyses. Conclusion In this SWIFT-DIRECT subanalysis, we did not find evidence for a significant interaction of the velocity of infarct growth on the odds of favourable outcome according to treatment by MT alone or combined IVT+MT. However, prior IVT was associated with significantly reduced occurrence of any ICH among slow progressors whereas this was increased in fast progressors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
奇奇苗苗发布了新的文献求助10
刚刚
liuxianglin2006完成签到,获得积分10
1秒前
七七七完成签到,获得积分10
1秒前
深情安青应助詹慧子采纳,获得10
2秒前
谦虚低调接地气完成签到,获得积分10
2秒前
2秒前
生动乐蕊完成签到,获得积分10
2秒前
郦映秋完成签到,获得积分10
3秒前
3秒前
ding应助独特的不尤采纳,获得30
3秒前
3秒前
JamesPei应助cjg采纳,获得30
4秒前
连国完成签到 ,获得积分10
4秒前
4秒前
5秒前
6秒前
研友_VZG7GZ应助跨材料采纳,获得10
6秒前
熊熊阁发布了新的文献求助10
7秒前
科研通AI6.2应助常璐旸采纳,获得10
8秒前
8秒前
8秒前
liangliang完成签到,获得积分10
8秒前
Druid完成签到,获得积分10
8秒前
ding应助奋斗的科研人采纳,获得10
9秒前
9秒前
溜溜发布了新的文献求助10
10秒前
地球发布了新的文献求助10
10秒前
Ycai发布了新的文献求助10
10秒前
研友_LMg3PZ发布了新的文献求助10
11秒前
11秒前
Vaibhav发布了新的文献求助10
12秒前
爆米花应助小正采纳,获得10
12秒前
李健应助寒冷班采纳,获得10
12秒前
天真曼荷完成签到,获得积分10
13秒前
13秒前
13秒前
学术小白发布了新的文献求助10
13秒前
王欣瑶完成签到 ,获得积分10
13秒前
wen发布了新的文献求助10
14秒前
亮亮发布了新的文献求助20
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
全相对论原子结构与含时波包动力学的理论研究--清华大学 500
Elevating Next Generation Genomic Science and Technology using Machine Learning in the Healthcare Industry Applied Machine Learning for IoT and Data Analytics 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6443241
求助须知:如何正确求助?哪些是违规求助? 8257113
关于积分的说明 17585207
捐赠科研通 5501710
什么是DOI,文献DOI怎么找? 2900830
邀请新用户注册赠送积分活动 1877821
关于科研通互助平台的介绍 1717487